GH AXIS RESEARCH

This category includes compounds relevant to laboratory research involving growth hormone axis signalling, receptor pathways, and endocrine system modelling. This category may include:

  • GHRH analogues
  • GH pathway modulators
  • Receptor-targeting compounds
  • Endocrine signalling research agents

Tesamorelin 5mg

£31.99
Description Stabilised GHRH analogue studied for fat metabolism. Technical Specifications Purity: ≥99% Usage & Handling Supplied as a lyophilised powder

Sermorelin 5mg

£27.99
Description Short-acting GHRH analogue studied for GH release. Technical Specifications Purity: ≥99% Usage & Handling Supplied as a lyophilised powder

Ipamorelin 5mg

£19.99
Description Growth hormone secretagogue stimulating GH release. Technical Specifications Purity: ≥99% MW: ~711 g/mol Usage & Handling Supplied as a

Tesamorelin 10mg

£44.99
Description Higher dose metabolic research peptide. Technical Specifications Purity: ≥99% Usage & Handling Supplied as a lyophilised powder for laboratory

Sermorelin 10mg

£54.99
Description Higher dose version for GH stimulation. Technical Specifications Purity: ≥99% Usage & Handling Supplied as a lyophilised powder for

CJC-1295 DAC 5mg

£33.99
Description Long-acting GHRH analogue for sustained GH release. Technical Specifications Purity: ≥99% MW: ~3367 g/mol Usage & Handling Supplied as

Ipamorelin 10mg

£29.99
Description Higher dose GH releasing peptide. Technical Specifications Purity: ≥99% MW: ~711 g/mol Usage & Handling Supplied as a lyophilised

Why Pepmatrix:

  • Batch-tested compounds
  • COA-backed inventory
  • UK-based dispatch
  • Secure packaging

All products within this category are batch-specific and may include supporting documentation such as:

  • Certificate of Analysis (COA)
  • Purity verification data
  • Batch / lot identification
  • Storage and handling guidelines

NOTE: All products are supplied for controlled laboratory environments and are not intended for human or veterinary use.